annual SGA:
$105.44M+$2.08M(+2.02%)Summary
- As of today (June 24, 2025), DNLI annual SGA is $105.44 million, with the most recent change of +$2.08 million (+2.02%) on December 31, 2024.
- During the last 3 years, DNLI annual SGA has risen by +$26.38 million (+33.37%).
- DNLI annual SGA is now at all-time high.
Performance
DNLI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$29.35M-$706.00K(-2.35%)Summary
- As of today (June 24, 2025), DNLI quarterly SGA is $29.35 million, with the most recent change of -$706.00 thousand (-2.35%) on March 31, 2025.
- Over the past year, DNLI quarterly SGA has increased by +$4.12 million (+16.31%).
- DNLI quarterly SGA is now -2.35% below its all-time high of $30.06 million, reached on December 31, 2024.
Performance
DNLI quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$5.95B-$453.94M(-8.26%)Summary
- As of today (June 24, 2025), DNLI TTM SGA is -$5.95 billion, with the most recent change of -$453.94 million (-8.26%) on March 31, 2025.
- Over the past year, DNLI TTM SGA has dropped by -$6.05 billion (-5967.13%).
- DNLI TTM SGA is now -5650.26% below its all-time high of -$103.51 million.
Performance
DNLI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DNLI Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | +16.3% | -5967.1% |
| 3 y3 years | +33.4% | +30.2% | -7300.5% |
| 5 y5 years | +126.8% | +133.8% | -10000.0% |
DNLI Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.4% | -2.4% | +38.7% | -147.0% | at low |
| 5 y | 5-year | at high | +126.8% | -2.4% | +133.8% | -270.9% | at low |
| alltime | all time | at high | +1964.2% | -2.4% | +863.7% | -5650.3% | at low |
DNLI Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $29.35M(-2.3%) | $109.56M(+3.9%) |
| Dec 2024 | $105.44M(+2.0%) | $30.06M(+20.5%) | $105.44M(+5.3%) |
| Sep 2024 | - | $24.95M(-1.0%) | $100.15M(-0.4%) |
| Jun 2024 | - | $25.19M(-0.2%) | $100.52M(-0.9%) |
| Mar 2024 | - | $25.24M(+1.9%) | $101.45M(-1.8%) |
| Dec 2023 | $103.35M(+14.2%) | $24.77M(-2.2%) | $103.35M(+1.2%) |
| Sep 2023 | - | $25.32M(-3.0%) | $102.10M(+2.1%) |
| Jun 2023 | - | $26.12M(-3.8%) | $100.03M(+5.2%) |
| Mar 2023 | - | $27.14M(+15.4%) | $95.07M(+5.1%) |
| Dec 2022 | $90.47M(+14.4%) | $23.52M(+1.1%) | $90.47M(+2.0%) |
| Sep 2022 | - | $23.26M(+9.9%) | $88.72M(+4.6%) |
| Jun 2022 | - | $21.16M(-6.1%) | $84.78M(+2.6%) |
| Mar 2022 | - | $22.54M(+3.6%) | $82.66M(+4.6%) |
| Dec 2021 | $79.06M(+31.1%) | $21.76M(+12.6%) | $79.06M(+5.0%) |
| Sep 2021 | - | $19.32M(+1.4%) | $75.29M(+4.9%) |
| Jun 2021 | - | $19.05M(+0.6%) | $71.78M(+7.6%) |
| Mar 2021 | - | $18.94M(+5.2%) | $66.71M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $60.33M(+29.8%) | $17.99M(+13.9%) | $60.33M(+13.4%) |
| Sep 2020 | - | $15.80M(+13.1%) | $53.21M(+9.4%) |
| Jun 2020 | - | $13.97M(+11.3%) | $48.62M(-2.2%) |
| Mar 2020 | - | $12.55M(+15.4%) | $49.73M(+7.0%) |
| Dec 2019 | $46.48M(+43.7%) | $10.88M(-3.0%) | $46.48M(-0.4%) |
| Sep 2019 | - | $11.21M(-25.6%) | $46.65M(+5.4%) |
| Jun 2019 | - | $15.08M(+61.9%) | $44.27M(+22.7%) |
| Mar 2019 | - | $9.31M(-15.7%) | $36.09M(+11.6%) |
| Dec 2018 | $32.35M(+106.3%) | $11.04M(+25.0%) | $32.35M(+22.7%) |
| Sep 2018 | - | $8.84M(+28.2%) | $26.37M(+23.8%) |
| Jun 2018 | - | $6.90M(+23.8%) | $21.31M(+18.5%) |
| Mar 2018 | - | $5.57M(+9.9%) | $17.98M(+14.6%) |
| Dec 2017 | $15.68M(+33.7%) | $5.07M(+34.3%) | $15.68M(+14.8%) |
| Sep 2017 | - | $3.77M(+5.9%) | $13.66M(+38.2%) |
| Jun 2017 | - | $3.56M(+8.9%) | $9.88M(+56.4%) |
| Mar 2017 | - | $3.27M(+7.5%) | $6.32M(+107.5%) |
| Dec 2016 | $11.73M(+129.7%) | $3.05M | $3.05M |
| Dec 2015 | $5.11M | - | - |
FAQ
- What is Denali Therapeutics annual SGA?
- What is the all time high annual SGA for Denali Therapeutics?
- What is Denali Therapeutics annual SGA year-on-year change?
- What is Denali Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Denali Therapeutics?
- What is Denali Therapeutics quarterly SGA year-on-year change?
- What is Denali Therapeutics TTM SGA?
- What is the all time high TTM SGA for Denali Therapeutics?
- What is Denali Therapeutics TTM SGA year-on-year change?
What is Denali Therapeutics annual SGA?
The current annual SGA of DNLI is $105.44M
What is the all time high annual SGA for Denali Therapeutics?
Denali Therapeutics all-time high annual SGA is $105.44M
What is Denali Therapeutics annual SGA year-on-year change?
Over the past year, DNLI annual SGA has changed by +$2.08M (+2.02%)
What is Denali Therapeutics quarterly SGA?
The current quarterly SGA of DNLI is $29.35M
What is the all time high quarterly SGA for Denali Therapeutics?
Denali Therapeutics all-time high quarterly SGA is $30.06M
What is Denali Therapeutics quarterly SGA year-on-year change?
Over the past year, DNLI quarterly SGA has changed by +$4.12M (+16.31%)
What is Denali Therapeutics TTM SGA?
The current TTM SGA of DNLI is -$5.95B
What is the all time high TTM SGA for Denali Therapeutics?
Denali Therapeutics all-time high TTM SGA is -$103.51M
What is Denali Therapeutics TTM SGA year-on-year change?
Over the past year, DNLI TTM SGA has changed by -$6.05B (-5967.13%)